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Objectives: to assess restenosis rates and blood pressure response after percutaneous transluminal renal angioplasty
(PTRA) in patients treated for fibromuscular dysplastic renal artery stenosis.
Methods: a prospective 12-month follow-up study of 27 patients with 31 treated renal artery stenosis. Follow-up
assessment included colour-coded duplex sonography (CCD) of renal arteries, monitoring of blood pressure, antihypertensive
medication, and creatinine measurements before discharge and at 3, 6, and 12 months. Primary end point was defined
as a haemodynamically significant restenosis >60% assessed by CCD.
Results: there was a cumulative 23% restenosis rate at 12 months. Arterial hypertension was cured or improved in 93%
of patients immediately after the intervention and remained cured/improved in 74% of patients at 12 months of follow-
up. Renal failure present in five patients before PTRA stabilised or improved in all patients.
Conclusions: although restenosis rate after PTRA in fibromuscular dysplasia is as high as in non-ostial atherosclerotic
lesions, there remains a considerable higher therapeutic effect. Profound pressure response and recurrent arterial
hypertension with restenosis support the high probability of a renovascular origin of arterial hypertension in this young
and otherwise healthy population compared to patients with atherosclerotic renal artery lesions.
Key Words: Endovascular therapy; Renal artery stenosis; Restenosis; Arterial hypertension; Colour-coded duplex sono-
graphy; Fibromuscular dysplasia.
Introduction The aim of this prospective, 12-months imaging
follow-up study was to assess restenosis rate, and
Renovascular disease is frequently associated with blood pressure response after technically successful
primary PTRA in patients with fibromuscular dys-hypertension and deteriorating renal function.1 Per-
cutaneous transluminal renal angioplasty (PTRA) with plasia.
or without stent placement has become the preferred
treatment.3,4 Few reports are devoted to fibromuscular
dysplasia, which accounts for about 10–15% of renal Methods
artery stenosis.4–6 Most studies lack prospective an-
giographic or duplex sonographic follow-up, and long- Patient selection
term results are based on blood pressure meas-
urements.4,5,7,8 The more favourable blood pressure All patients included in this prospective follow-up
control in patients with fibromuscular dysplastic renal study were treated at the University Hospital, Division
artery stenosis suggests a lower incidence of re- of Angiology, Bern, Switzerland, from January 1994
stenosis.4,7 However, we and others have shown that through April 1999. Thirty-three consecutive patients
recurrence of renovascular hypertension after PTRA underwent 39 primary catheter procedures for renal
cannot be attributed to restenosis with certainty,9–11 artery stenosis due to fibromuscular dysplasia. Five
and that direct examination of the renal artery is patients with borderline angiographic results were
needed to determine the true anatomic restenosis rate.12 excluded from the series because of non-significant
(<60%) stenosis defined by colour-coded duplex sono-
graphy (CCD).12 One patient had to be excluded be-
∗ Please address all correspondence to: I. Baumgartner, Swiss Cardio- cause of rather atherosclerotic origin of the stenosis.13vascular Center, Division of Angiology, Inselspital, CH-3010 Bern,
Switzerland. Final study population therefore comprised 22 women
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Table 1. Demographic data of 27 patients treated for fibromuscular Doppler wave forms, with an absent early systolic
dysplastic renal artery stenosis. peak indicating a [60% stenosis.12
Characteristic Patients Postinterventional blood pressure response was fol-
n (%) lowed using an automatic sphygmo-manometry de-
vice with measurements every 12 h up to 6 h, and at 6 hHypertension 27 (100)
Renal insufficiency (se-creatinine >115 mol/l) 5 (19) intervals up to 24 h. Before discharge, patency of the
treated renal artery was documented by CCD, serum
Gender: Woman 22 (81) creatinine levels was measured to catch an inter-Age (median and range) 45 (19–70)
Ischaemic heart disease 1 (4) vention-related increase. Follow-up assessment in-
Cerebrovascular disease 2 (7) cluded blood pressure, antihypertensive drugs, serum
Hypercholesterolaemia 5 (18) creatinine, and CCD of renal arteries at 3, 6, andDiabetes 1 (4)
Smoker 8 (29) 12 months after the intervention. All patients with
suspected restenosis on the basis of CCD underwent
intraarterial digital subtraction angiography including
selective renovascular assessment followed by PTRA.and five men with 31 renal arteries treated for [60%
The primary end point of the study was defined asstenosis associated with arterial hypertension and/or
sonographic evidence of the first restenosis [60%renal failure. Treatment involved the main renal artery
verified by selective angiography.in 26 cases, an inferior accessory artery in four cases
and a segmental artery in one case, respectively. Demo-
graphic data of the study population are shown in
Table 1. No further fibromuscular dysplastic lesions
Technique of angioplasty and procedural protocolwere found by colour-coded duplex sonography.
The technique of renal angioplasty has been described
elsewhere. In brief, in all cases a multiplane pre-
Diagnostic workup and follow-up assessment interventional angiography (anterior-posterior, right
anterior-oblique, left anterior-oblique) and selective
The diagnostic workup included medical history, documentation with low contrast and high frame rate
physical examination, serum creatinine, and blood (2–3 s) was performed. Catheter passage of the stenosis
pressure measurements on two separate occasions, at was preceded by injection of 5000 IU of heparin. The
least 2 weeks apart. The diagnosis of renal artery renal artery orifice was catheterised using preformed
stenosis due to fibromuscular dysplasia based on clin- 5F catheters (i.e. cobra-shaped, single curved, side-
ical aspects, absent atherosclerotic changes of the aorta winder). Routinely, a soft 0.035″ hydrophilic guidewire
and a non-ostial localisation in CCD, verified by angio- was advanced across the stenosis and placed in a
graphy when a typical string-of- beads stenosis was peripheral branch. The 5F catheter was then pushed
present. The main impact of angiography was to com- forward over the stenosis, followed by replacement of
bine diagnostics with an interventional treatment of a the hydrophilic guidewire with a rigid steerable 0.020″
CCD-verified restenosis. Haemodynamic significance wire with 4 cm flexible gold tip. Balloon angioplasty
was defined as [60% diameter reduction by CCD. was performed by over-the-wire technique. The bal-
All sonographic examinations were performed by loon diameter was selected equal to or slightly larger
an experienced examiner following criteria validated than the estimated diameter of the renal artery.
before.14,15 A 2.5–4.5 MHz phased array transducer (128
XP 10, Acuson, Mountain View, CA, U.S.A.) was used.
Direct examination was performed to assess the aorta
and renal arteries.15–17 The peak systolic velocity (PSV) Definition of technical and functional results
of the aorta was measured at or above the level of
the superior mesenteric artery. A [60% renal artery Primary technical success was defined as visually es-
timated angiographic residual stenosis <60% withstenosis was defined as angle-corrected, peak systolic
velocity (PSV) >180 cm/s, and a renal-aortic flow ve- completion of the procedure, and a CCD with a RAR
<3.5 before discharge. No pressure gradient meas-locity ratio (RAR) >3.5.15 A moderate 30–59% renal
artery stenosis was defined as PSV >180 cm/s and urements were taken because of increased risk of
dissection or perforation in patients with fibroplasticRAR <3.5, and a <30% stenosis as PSV <180 m/s
and RAR <3.5. Direct renal artery assessment was renal artery disease.
Blood pressure response after PTRA was classifiedsupplemented by analysis of intraparenchymatous
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according to a modification of the Cooperative Study
of Renovascular Hypertension:18 (1) cured, diastolic
blood pressure (DBP) less than 90 mmHg and no
hypertensive medications; (2) improved, DBP less than
90 mmHg and/or a decrease in the number of med-
ications or a decrease in diastolic pressure of at least
15% but medication still required; (3) unchanged, if
there was a smaller drop in pressure or no decrease
at all.
Patients were evaluated for response on renal func-
tion, if their serum creatinine level was [115 mol/l
before intervention. Response was classified as im-
proved (decrease in serum creatinine level [15%), no
change (serum creatinine ±15%) or deterioration of
Fig. 1. Cumulative primary patency-rate after percutaneous trans-renal function (increase in serum creatinine [15%).
luminal renal angioplasty (PTRA) in 31 fibromuscular dysplastic
renal artery stenosis.
Statistical analysis
Quantitative values were shown as mean±standard
deviation (s.d.). Cumulative primary patency was cal-
culated using the life table analysis. For statistical
analysis of continuous data as blood pressure and
serum creatinine, a two-tailed non-parametric test was
used to assess differences over time (Wilcoxon U-test).
Categorical data presented as rates were compared
using contingency tables (Fisher’s Exact-Test). A p-
value less than 0.05 was considered statistically sig-
nificant.
Fig. 2. Mean (±s.d.) systolic and diastolic blood pressure in 27Results
patients with fibromuscular dysplastic renal artery stenosis before
and within 24 h after percutaneous transluminal angioplasty (PTRA).
None of the 27 patients included in the series was lost ∗ and ∗∗ p<0.001 compared to baseline.
from follow-up. Mean follow-up was 10±4 months
with documented sonographic restenosis defined as months, wherefrom one was an in-stent restenosis.
primary study end point. Among them, all were located at the site of previous
All procedures were successfully performed except PTRA, and may thus be regarded as true restenoses.
for one patient with a flow compromising dissection. Primary patency rate at 6 and 12 months, calculated
A stent (Palmaz, 4–9/15 mm) had to be placed. There by the life table method, was 81% and 77%, respectively
were no serious adverse events associated with the (Fig. 1).
interventions. Seven patients had a small haematoma Evidence of a persistent moderate residual stenosis
at the puncture side. A transient procedure-related (30–59%) after the catheter intervention as determined
increase of the serum creatinine level from 197 mol/ by CCD before discharge, represented a strong pre-
l before to 238 mol/l after the intervention occurred dictor for the development of a restenosis (p=0.004).
in one patient.
Effect on blood pressure and renal function
Primary patency
Technically successful angioplasty was followed by a
prompt decrease in blood pressure within 24 h in 25In seven of 31 renal arteries treated by PTRA for the
first time a restenosis [60% developed within 12 patients (93%) (Fig. 2). At 3 months there were six
Eur J Vasc Endovasc Surg Vol 23, February 2002
Treatment of Renal Artery Fibromuscular Dysplasia with Balloon Angioplasty 149
Discussion
In this prospective, sonographic follow-up study eval-
uating results of PTRA in patients with renal artery
stenosis due to fibromuscular disease, the primary 12-
month patency rate was 77%, and persistent im-
provement/cure of arterial hypertension was docu-
mented in 74% of patients.
Among the published series presenting long-term
outcome after successful PTRA in atherosclerotic renal
artery stenosis or fibromuscular dysplasia3,5,7,19 several
do not report results of follow-up angiography and
provide results from follow-up angiography in a mi-
nority of patients selected on the basis of recurrent
hypertension.3,7,19 Therefore, restenosis rates given
Fig. 3. Mean (±s.d.) systolic and diastolic blood pressure in 27
might be misleading, since recurrence of arterial hyper-patients with fibromuscular dysplastic renal artery stenosis before,
at 3, 6 and 12 months after percutaneous transluminal angioplasty tension and renal artery restenosis do not correlate
(PTRA). ∗ and ∗∗ p<0.001 compared to baseline. well.9–11 Oertle et al.9 have shown that about one third
of patients with deterioration of/or recurrent arterial
hypertension after PTRA have no restenosis, whereas
patients with a documented restenosis, five with de- 15% of patients without deterioration of/or recurrent
terioration of/or recurrent hypertension, resulting in arterial hypertension have restenosis at follow-up
20 of 27 (74%) patients with improvement of blood angiography.
pressure control. At 12 months there was one patient A few series state angiography6 or CCD11,20 as stand-
with a documented restenosis without deterioration ard follow-up procedure to document true anatomic
of/or recurrent hypertension, so finally 20 of 27 restenosis rate after PTRA with or without stenting.patients (74%) had an improved blood pressure control
Plouin et al.6 present follow-up angiography in 92 ofor were cured from arterial hypertension at 1 year of
104 patients with 59 atherosclerotic and 33 fibro-follow-up. Recurrent arterial hypertension was a
muscular dysplastic renal artery stenosis treated bystrong clinical indicator to suggest a restenosis
angioplasty (follow-up 8.8±6.0 months; 80% within(p<0.01). In our series all restenotic lesions were treated
5–15 months). Restenosis rate in patients with fibro-by a second PTRA in six, and an aorto-renal bypass in
muscular dysplasia was 12% at 9±6 months of follow-one patient with a single kidney, respectively. Overall,
up. The significantly lower recurrence rate comparedmean changes ±s.d. in systolic and diastolic blood
to results presented in this series might be explainedpressure immediately after PTRA, and during 12
by underestimation of diameter reduction using non-months follow-up, are shown in Fig. 2 and Fig. 3,
selective angiography (Fig. 4). Membranous, septi-respectively. The difference in systolic and diastolic
forme stenosis in fibromuscular dysplasia are fre-blood pressure 24 h and 12 months after PTRA com-
quently superimposed by mural microaneurysm, andpared to baseline was statistically significant
graduation of stenosis is difficult even when selective(p<0.0001). Antihypertensive medication was reduced
angiography is used.5 Gowda et al.21 could demonstratefrom an average of 1.8±1.0 to 1.0±1.1 drugs per day
by CCD renal artery flow patterns suggestive of FMDat 3 months (p=0.04), and had to be increased to
even when angiography was borderline or normal.1.1±1.0 at 12 months of follow-up (NS).
CCD is a well established method combining directThere were five patients with an impaired renal
visualisation of anatomical structures with measure-function (serum creatinine level [115 mol/l) before
ment of flow haemodynamics. CCD is particularlyPTRA. Serum creatinine in five patients with renal
well suited for graduation of renal artery stenosis, andimpairment before, at 3 and 12 months after PTRA
follow-up documentation in fibromuscular dysplasiawas 197 (range 138–500) mol/l, 140 (98–252) mol/
because peak velocity measurements are not in-1, and 152 (98–219) mol/l, respectively. None of the
fluenced by heterogenous vessel wall changes typicalpatients reached end-stage renal failure during the 12
for fibromuscular dysplasia.months follow-up period. Overall serum creatinine
In comparison to Plouin6 and Baumgartner11 therenormalized in two patients (40%), and decreased
seems to be no statistically significant difference in the(>15%) in one or was stabilised with no further de-
terioration in two patients (60%). restenosis rate between non-ostial atheromatous and
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Fig. 4. A 50-year old patient with severe arterial hypertension and fibromuscular dysplasia of the right renal artery. A. Digital subtraction
angiography before intervention demonstrating the classic string-of-beads stenoses in the middle to distal part of the right renal artery.
B. Selective angiography before intervention. C. Angiographic control immediately after percutaneous angioplasty. A 5/40 mm angioplasty
balloon catheter was used.
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the initial lesions, whereas the excessive restenosis rate
of ostial atherosclerotic lesions are due to recoiling of
aortic wall plaques.22–24 Whether a recently discovered
polymorphism of the renal artery stenosis in patients
with multifocal FMD has influence on the restenosis
rate after PTRA is of question.25
In our series technically successful angioplasty was
followed by a prompt decrease in blood pressure in
25 of 27 patients (93%). At 12 months of follow-up
74% (20/27) of patients were still considered improved
or cured from arterial hypertension. Comparison with
other published series is difficult, because there is a
large variation of selection criteria, blood pressure
definition and length of follow-up. In consideration of
the afore-mentioned limitations, our results are in
accordance to Klinge,8 Sos7 and Ramsay.4 Klinge et al.8
report a cure rate of 38% (18/47), and an improved
blood pressure control in 55% (26/47) of patients at 6
months of follow-up. Sos et al.7 report an immediate
cure rate of 59% (16/27), and an improved arterial
blood pressure control in 33% (9/27) of patients. At
12 months of follow-up eight of ten patients (87%)
required no antihypertensive medication. In a me-
taanalysis presented by Ramsay,4 the overall cure rate
was 50% in patients with fibromuscular dysplasia,
and 19% in patients with atherosclerotic renal artery
stenosis.
Data with regard to renal function in patients with
fibromuscular dysplasia are limited.4,26,27 In this series
there were five patients with a serum creatinine
[115 mol/l before PTRA. Serum creatinine stabilisedFig. 5. A. Colour-coded duplex sonography showing a high grade
or improved in all five patients.renal artery stenosis (mid-portion, arrow) before angioplasty.
Peak systolic velocity (PSV) >200 cm/s and renal aortic flow Limitations of the study are a small sample size and
velocity ratio (RAR) >3.5. B. Colour-coded duplex sonography missing histological correlation. However, first the24 h after angioplasty with normalised flow velocities indicating
largest series described in the literature5 included 66technically successful intervention. PSV 150 cm/s and RAR <3.5.
patients with 85 fibromuscular dysplastic lesions
treated by angioplasty, but angiographic follow-up
was limited to 10 patients. Second, although we mightfibromuscular dysplastic renal arteries stenoses. Earlier
have missed lesions due to intimal or periadventitialstudies reporting catheter-based treatment of fibro-
fibroplasia because there is no classical angiographicmuscular dysplastic renal artery stenosis lead to the
appearance of string-of-beads stenoses,28 this may havesuggestion that patients with fibromuscular dysplasia
accounted for less than 10% of our patients withmay have a lower restenosis rate because of a more
fibromuscular dysplasia.profound and persistent control of arterial hyper-
In summary, whereas postinterventional restenosistension.5,7,8 This was, however, more probably related
rate in fibromuscular dysplasia is as high as in non-to the younger age of patients, and the less often
ostial atherosclerotic lesions, there remains a con-multifactorial origin of the hypertension compared to
siderable higher therapeutic effect on arterial hyper-patients with atheromatous renal artery disease. Our
tension. Profound arterial blood pressure response andfindings that fibromuscular dysplasia and reported
recurrent arterial hypertension with restenosis supportnon-ostial atheromatous renal artery disease have both
the high probability of a renovascular origin of arterialsimilar restenosis rates after endovascular in-
hypertension in this young and otherwise healthyterventions fit well with the concept that neointimal
population compared to patients with atherosclerotichyperplasia and vascular remodeling are main causes
of restenosis independent of histopathologic nature of renal artery lesions.
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